Home / News Center / Policy & Regulation
News Center · Policy & RegulationAn AI Clone of Actress Wu Yue Sold RMB 1.1m of Serum Before the Ban
*MZ Toutiao (美妆头条) · 2026-10-23 · AI / E-commerce* **原文:** AI“偷脸”吴越、邓亚萍带货,一款抗皱精华销售额超110万 At three in the morning on 18 October, actress Wu Yue posted that a Douyin account, “Sister Hua's Skincare Diary”, had used an AI-generated clone of her face and voice to sell a product she had never endorsed. The videos pushed IRY's recombinant collagen soothing essence at about RMB 70 for 30 vials, added a “safe even in pregnancy” claim, and spliced in AI clips of table-tennis champion Deng Yaping to borrow credibility. Before the account was permanently banned and its content wiped that morning, the listing had moved more than 7,300 units in 30 days and 16,720 cumulatively, with over 2,200 positive reviews — roughly RMB 1.1m of sales at list price. Deng Yaping's team confirmed that no endorsement or AI authorisation had ever been granted. MZ Toutiao frames this as a trust problem arriving precisely in the 11.11 pre-sale window: AI is now standard in beauty e-commerce, but the legal boundary around likeness, voice and platform liability is not. Earlier victims include Wen Zhengrong, Zhang Xinyu, Qi Wei and academician Zhang Boli. Detail --- AI clone of actress Wu Yue IRY recombinant collagen
Related
Regulatory View: Compliance Paths and Standards for Soluble Microcrystal Patches
Dissolving microneedle products face a dual regulatory path of cosmetics versus medical devices:…
E-commerce sampling compliance rate rises: Where the next growth curve lies
E-commerce sampling compliance rate rises has been gaining momentum. Data shows that in Q4, onli…
Children’s cosmetics rules tighten further: Reading competitive dynamics from the supply side
Children’s cosmetics rules tighten further has been gaining momentum. Data shows that in Q3, new…
New ingredient filings hit a record high: New dividends from shifting channels
New ingredient filings hit a record high has been gaining momentum. Data shows that in Q2, top-b…